Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Policybazaar ropes in Amitabh Bachchan for insurance awareness movement
Policybazaar has appointed veteran actor Amitabh Bachchan as its brand ambassador. This move initiates a significant movement for health and term insurance awareness nationwide. The initiative aligns with IRDAI's vision of providing insurance for all Indians by 2047. Bachchan's established image of trust will encourage families to prioritize financial protection. This campaign aims to secure the future of over 140 crore Indians.
'Why argue with someone you don't trust?' Anthropic CEO Dario Amodei appears to take swipe at Sam Altman
Anthropic CEO Dario Amodei has shed fresh light on his decision to leave OpenAI in 2020, suggesting a lack of trust and differing visions played a key role.
Bombay HC rejects Lilavati Trust's defamation plea, says HDFC Bank's claims were truthful
The Bombay High Court on Tuesday dismissed an interim application filed by the Lilavati Kirtilal Mehta Medical Trust, which runs Mumbai's Lilavati Hospital, seeking to restrain HDFC Bank, its Managing Director and CEO Sashidhar Jagdishan, and others from making allegedly defamatory statements against the Trust and its members.
GRM Overseas Ltd leads losers in 'B' group
Bafna Pharmaceuticals Ltd, Agri-Tech (India) Ltd, Master Trust Ltd and Alacrity Securities Ltd are among the other losers in the BSE's 'B' group today, 09 June 2026.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Bombay HC quashes ₹2-crore bribery FIR against HDFC Bank CEO Sashidhar Jagdishan
This was in connection with a bribery complaint filed by the Lilavati Kirtilal Mehta Medical Trust, which runs Lilavati Hospital in Mumbai. Shares of HDFC Bank Ltd ended at ₹772.55, down by ₹5.35, or 0.69%, on the BSE today, May 5.
NHAI-backed Raajmarg Infra Investment Trust's IPO to open on Mar 11
State-owned NHAI-sponsored Raajmarg Infra Investment Trust (RIIT) is gearing up to launch its Rs 6,000 crore Initial Public Offering (IPO). The InvIT's maiden public offering will open on March 11 and conclude on March 13, while the bidding for anchor investors will take place on March 10, according to a public announcement on Monday. The initiative marks an important step in broadening public participation in the National Highway infrastructure growth story. The public InvIT aims to unlock the monetisation potential of the National Highway assets while creating a high-quality, long-term investment instrument primarily targeting retail and domestic investors. As per the Red Herring Prospectus (RHP), Raajmarg Infra Investment Trust's IPO issue size aggregates up to Rs 6,000 crore. This was an increase from Rs 5,700 crore planned at the time of filing draft papers in January. Earlier, NHAI had incorporated Raajmarg Infra Investment Managers Pvt. Ltd. (RIIMPL) as the investment mana
Promoters sell Rs 930 crore worth Alkem Labs shares to domestic, global investors
Promoter Sarandhar Singh, on behalf of Samprada & Nanhamati Singh Family Trust, holds 18.75 percent stake in Alkem Labs.
Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore
The block deal worth Rs 930 crore in Alkem Laboratories today follows reports that the Samprada and Nanhamati Family Trust was looking to sell up to a 1.5 percent stake in the pharmaceutical company.